Testing effectiveness (Phase 2)Study completedNCT00030667
What this trial is testing
Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood
Who this might be right for
Childhood Desmoplastic Small Round Cell TumorChildhood Synovial SarcomaGastrointestinal Stromal Tumor+5 more
National Cancer Institute (NCI) 100